Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Abstract 1668: A comparative study of curated contents by knowledge-based curation system in cancer clinical sequencing

Masayuki Takeda, Kazuko Sakai, Shigeki Shimizu, Takayuki Takahama, Takeshi Yoshida, Satomi Watanabe, Tsutomu Iwasa, Kimio Yonesaka, Shinichiro Suzuki, Hidetoshi Hayashi, Hisato Kawakami, Yoshikane Nonagase, Kaoru Tanaka, Junji Tsurutani, Kazumasa Saigo, Akihiko Ito, Tetsuya Mitsudomi, Kazuhiko Nakagawa, Kazuto Nishio

Cancer Res (2019) 79 (13_Supplement): 1668.

https://doi.org/10.1158/1538-7445.AM2019-1668

Published: 01 July 2019

View article titled, Abstract 1668: A comparative study of curated contents by knowledge-based curation system in cancer clinical sequencing

Journal Articles

Abstract 4853: NRP2b, a unique isoform of NRP2, promotes aggressive lung cancer phenotypes

Anastasios Dimou, Patrick Nasarre, Joyce Nair-Menon, Federico Cappuzzo, Lorenza Landi, Armida D'Incecco, Hidetaka Uramato, Takeshi Yoshida, Eric Haura, Monica Gooz, Kent Armeson, Robert Gemmill, Harry Drabkin

Cancer Res (2017) 77 (13_Supplement): 4853.

https://doi.org/10.1158/1538-7445.AM2017-4853

Published: 01 July 2017

View article titled, Abstract 4853: NRP2b, a unique isoform of NRP2, promotes aggressive lung cancer phenotypes

Journal Articles

Abstract 1736: Src inhibitor dasatinib enhances anti-tumor activity of irreversible or T790M-selective epidermal growth factor receptor-tyrosine kinase inhibitors in non-small cell lung cancer cells with T790M gate-keeper mutation

Takeshi Yoshida, Guolin Zhang, Yun Bai, Arthur Edwards, Bin Fang, Bhupendra Rawal, Takafumi Okabe, Isamu Okamoto, Kazuhiko Nakagawa, Eric B. Haura

Cancer Res (2011) 71 (8_Supplement): 1736.

https://doi.org/10.1158/1538-7445.AM2011-1736

Published: 15 April 2011

View article titled, Abstract 1736: Src inhibitor dasatinib enhances anti-tumor activity of irreversible or T790M-selective epidermal growth factor receptor-tyrosine kinase inhibitors in non-small cell lung cancer cells with T790M gate-keeper mutation

Journal Articles

Abstract 5128: Physical EGFR network mapping and dynamic regulation in lung cancer cells

Jiannong Li, Keiryn Bennett, Lanxi Song, Yun Bai, Takeshi Yoshida, Arthur Edwards, Fumi Kinose, Bin Fang, Guolin Zhang, Ines Kaupe, Florian Greben, Giulio Superti-Furga, Eric Haura

Cancer Res (2011) 71 (8_Supplement): 5128.

https://doi.org/10.1158/1538-7445.AM2011-5128

Published: 15 April 2011

View article titled, Abstract 5128: Physical EGFR network mapping and dynamic regulation in lung cancer cells

Journal Articles

Abstract 5460: Identification of c-Src as a potential therapeutic target for gastric cancer and of MET activation as a cause of resistance to c-Src inhibition

Wataru Okamoto, Isamu Okamoto, Takeshi Yoshida, Erina Hatashita, Yuki Yamada, Kiyoko Kuwata, Tokuzo Arao, Kazuyoshi Yanagihara, Kazuto Nishio, Masahiro Fukuoka, Kazuhiko Nakagawa

Cancer Res (2010) 70 (8_Supplement): 5460.

https://doi.org/10.1158/1538-7445.AM10-5460

Published: 15 April 2010

View article titled, Abstract 5460: Identification of c-Src as a potential therapeutic target for gastric cancer and of MET activation as a cause of resistance to c-Src inhibition

Journal Articles

Differential constitutive activation of the epidermal growth factor receptor (EGFR) in non-small cell lung cancer cells bearing EGFR mutation and amplification

Takafumi Okabe, Isamu Okamoto, Kenji Tamura, Masaaki Terashima, Takeshi Yoshida, Taroh Satoh, Minoru Takada, Masahiro Fukuoka, Kazuhiko Nakagawa

Cancer Res (2008) 68 (9_Supplement): 3538.

Published: 01 May 2008

View article titled, Differential constitutive activation of the epidermal growth factor receptor (EGFR) in non-small cell lung cancer cells bearing<em> EGFR</em> mutation and amplification

Journal Articles

Matuzumab and cetuximab activate the epidermal growth factor receptor but fail to trigger downstream signaling by akt or erk

Takeshi Yoshida, Isamu Okamoto, Takafumi Okabe, Tsutomu Iwasa, Taroh Satoh, Kazuto Nishio, Masahiro Fukuoka, Kazuhiko Nakagawa

Cancer Res (2008) 68 (9_Supplement): 2749.

Published: 01 May 2008

View article titled, Matuzumab and cetuximab activate the epidermal growth factor receptor but fail to trigger downstream signaling by akt or erk

Journal Articles

Differential Constitutive Activation of the Epidermal Growth Factor Receptor in Non–Small Cell Lung Cancer Cells Bearing EGFR Gene Mutation and Amplification

Takafumi Okabe, Isamu Okamoto, Kenji Tamura, Masaaki Terashima, Takeshi Yoshida, Taroh Satoh, Minoru Takada, Masahiro Fukuoka, Kazuhiko Nakagawa

Cancer Res (2007) 67 (5): 2046–2053.

https://doi.org/10.1158/0008-5472.CAN-06-3339

Published: 01 March 2007

View article titled, Differential Constitutive Activation of the Epidermal Growth Factor Receptor in Non–Small Cell Lung Cancer Cells Bearing <em>EGFR</em> Gene Mutation and Amplification

Journal Articles

ZNF143 activates gene expression in response to DNA damage, and binds to cisplatin-modified DNA

Tetsuro Wakasugi, Hiroto Izumi, Takeshi Yoshida, Tomonori Igarashi, Ichiro Niina, Takuya Imaizumi, Yasutomo Momii, Kimitoshi Kohno

Cancer Res (2005) 65 (9_Supplement): 349.

Published: 01 May 2005

View article titled, ZNF143 activates gene expression in response to DNA damage, and binds to cisplatin-modified DNA

Journal Articles

DNA topoisomerase II poison TAS-103 transactivates GC-box-dependent transcription via acetylation of Sp1

Takeshi Yoshida, Hiroto Izumi, Takayuki Torigoe, Tetsuro Wakasugi, Ichiro Niina, Tomonori Igarashi, Takuya Imaizumi, Yasutomo Momii, Kimitoshi Kohno

Cancer Res (2005) 65 (9_Supplement): 1174.

Published: 01 May 2005

View article titled, DNA topoisomerase II poison TAS-103 transactivates GC-box-dependent transcription via acetylation of Sp1

Journal Articles

Adoptive Immunotherapy by Pantropic Killer Cells Recovered from OK-432-injected Tumor Sites in Mice

Motoo Saito, Masaki Nanjo, Motoyuki Kataoka, Yoichiro Moriya, Yutaka Sugawara, Takeshi Yoshida, Nakao Ishida

Cancer Res (1988) 48 (15): 4163–4167.

Published: 01 August 1988

View article titled, Adoptive Immunotherapy by Pantropic Killer Cells Recovered from OK-432-injected Tumor Sites in Mice

NARROW

Abstract 1668: A comparative study of curated contents by knowledge-based curation system in cancer clinical sequencing

Abstract 4853: NRP2b, a unique isoform of NRP2, promotes aggressive lung cancer phenotypes

Abstract 1736: Src inhibitor dasatinib enhances anti-tumor activity of irreversible or T790M-selective epidermal growth factor receptor-tyrosine kinase inhibitors in non-small cell lung cancer cells with T790M gate-keeper mutation

Abstract 5128: Physical EGFR network mapping and dynamic regulation in lung cancer cells

Abstract 5460: Identification of c-Src as a potential therapeutic target for gastric cancer and of MET activation as a cause of resistance to c-Src inhibition

Differential constitutive activation of the epidermal growth factor receptor (EGFR) in non-small cell lung cancer cells bearing EGFR mutation and amplification

Matuzumab and cetuximab activate the epidermal growth factor receptor but fail to trigger downstream signaling by akt or erk

Differential Constitutive Activation of the Epidermal Growth Factor Receptor in Non–Small Cell Lung Cancer Cells Bearing EGFR Gene Mutation and Amplification

ZNF143 activates gene expression in response to DNA damage, and binds to cisplatin-modified DNA

DNA topoisomerase II poison TAS-103 transactivates GC-box-dependent transcription via acetylation of Sp1

Adoptive Immunotherapy by Pantropic Killer Cells Recovered from OK-432-injected Tumor Sites in Mice

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only